文献速递临床试验与 GCP

肺保护性通气基础上强化与中度肺泡复张策略对术后肺部并发症的影响:一项随机临床试验

Effect of Intensive vs Moderate Alveolar Recruitment Strategies Added to Lung-Protective Ventilation on Postoperative Pulmonary Complications: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2017-01-01

该随机临床试验在巴西单中心ICU纳入心脏术后低氧血症患者320例,比较强化与中度肺泡复张策略联合小潮气量肺保护性通气。强化组肺部并发症严重程度评分分布优于中度组(共同OR 1.86,95%CI 1.22-2.83,P=0.003),住院时间更短,而医院死亡率和气压伤发生率无显著差异。

要点

  • 强化肺泡复张策略可降低心脏术后低氧血症患者肺部并发症严重程度评分。
  • 强化组住院时间较中度组缩短1.5天,ICU时间缩短1.0天。
  • 两组医院死亡率和气压伤发生率无显著差异。

核心结论

  • 心脏术后低氧血症患者采用强化与中度肺泡复张策略相比,住院期间肺部并发症严重程度更轻。

研究设计与样本

  • 随机临床试验,在巴西单中心ICU进行,纳入2011年12月至2014年心脏术后低氧血症患者。
  • 强化复张策略组n=157,中度复张策略组n=163,均联合小潮气量肺保护性通气。
  • 全部320例患者完成试验,中位年龄62岁(IQR 56-69岁),女性125例(39%)。

主要发现

  • 强化组肺部并发症评分均值1.8(95%CI 1.7-2.0)、中位数1.7(IQR 1.0-2.0),中度组均值2.1(95%CI 2.0-2.3)、中位数2.0(IQR 1.5-3.0)。
  • 总体评分分布向有利于强化策略方向偏移,较低评分的共同OR为1.86(95%CI 1.22-2.83,P=0.003)。
  • 中度组平均住院12.4天 vs 强化组10.9天(绝对差-1.5天,95%CI -3.1至-0.3,P=0.04)。
  • 中度组平均ICU停留4.8天 vs 强化组3.8天(绝对差-1.0天,95%CI -1.6至-0.2,P=0.01)。
  • 医院死亡率强化组2.5% vs 中度组4.9%(绝对差-2.4%,95%CI -7.1%至2.2%),气压伤发生率强化组0% vs 中度组0.6%(绝对差-0.6%,95%CI -1.8%至0.6%,P=0.51),均无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Perioperative lung-protective ventilation has been recommended to reduce pulmonary complications after cardiac surgery. The protective role of a small tidal volume (VT) has been established, whereas the added protection afforded by alveolar recruiting strategies remains controversial. OBJECTIVE: To determine whether an intensive alveolar recruitment strategy could reduce postoperative pulmonary complications, when added to a protective ventilation with small VT. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial of patients with hypoxemia after cardiac surgery at a single ICU in Brazil (December 2011-2014). INTERVENTIONS: Intensive recruitment strategy (n=157) or moderate recruitment strategy (n=163) plus protective ventilation with small VT. MAIN OUTCOMES AND MEASURES: Severity of postoperative pulmonary complications computed until hospital discharge, analyzed with a common odds ratio (OR) to detect ordinal shift in distribution of pulmonary complication severity score (0-to-5 scale, 0, no complications; 5, death). Prespecified secondary outcomes were length of stay in the ICU and hospital, incidence of barotrauma, and hospital mortality. RESULTS: All 320 patients (median age, 62 years; IQR, 56-69 years; 125 women [39%]) completed the trial. The intensive recruitment strategy group had a mean 1.8 (95% CI, 1.7 to 2.0) and a median 1.7 (IQR, 1.0-2.0) pulmonary complications score vs 2.1 (95% CI, 2.0-2.3) and 2.0 (IQR, 1.5-3.0) for the moderate strategy group. Overall, the distribution of primary outcome scores shifted consistently in favor of the intensive strategy, with a common OR for lower scores of 1.86 (95% CI, 1.22 to 2.83; P = .003). The mean hospital stay for the moderate group was 12.4 days vs 10.9 days in the intensive group (absolute difference, -1.5 days; 95% CI, -3.1 to -0.3; P = .04). The mean ICU stay for the moderate group was 4.8 days vs 3.8 days for the intensive group (absolute difference, -1.0 days; 95% CI, -1.6 to -0.2; P = .01). Hospital mortality (2.5% in the intensive group vs 4.9% in the moderate group; absolute difference, -2.4%, 95% CI, -7.1% to 2.2%) and barotrauma incidence (0% in the intensive group vs 0.6% in the moderate group; absolute difference, -0.6%; 95% CI, -1.8% to 0.6%; P = .51) did not differ significantly between groups. CONCLUSIONS AND RELEVANCE: Among patients with hypoxemia after cardiac surgery, the use of an intensive vs a moderate alveolar recruitment strategy resulted in less severe pulmonary complications while in the hospital. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01502332.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Costa Leme A, Hajjar LA, Volpe MS, et al. Effect of Intensive vs Moderate Alveolar Recruitment Strategies Added to Lung-Protective Ventilation on Postoperative Pulmonary Complications: A Randomized Clinical Trial. JAMA. 2017. PMID: 28322416. doi:10.1001/jama.2017.2297

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。